Display options
Cite
Nelson AW, Groen AJ, Miller JL, et al. Corrigendum to "Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity" [Mol. Cell Endocrinol. 440 (2016) 138-150]. Mol Cell Endocrinol. 2017;443:175doi: 10.1016/j.mce.2017.01.048.
Nelson, A. W., Groen, A. J., Miller, J. L., Warren, A. Y., Holmes, K. A., Tarulli, G. A., Tilley, W. D., Katzenellenbogen, B. S., Hawse, J. R., Gnanapragasam, V. J., & Carroll, J. S. (2017). Corrigendum to "Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity" [Mol. Cell Endocrinol. 440 (2016) 138-150]. Molecular and cellular endocrinology, 443175. https://doi.org/10.1016/j.mce.2017.01.048
Nelson, A W, et al. "Corrigendum to "Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity" [Mol. Cell Endocrinol. 440 (2016) 138-150]." Molecular and cellular endocrinology vol. 443 (2017): 175. doi: https://doi.org/10.1016/j.mce.2017.01.048
Nelson AW, Groen AJ, Miller JL, Warren AY, Holmes KA, Tarulli GA, Tilley WD, Katzenellenbogen BS, Hawse JR, Gnanapragasam VJ, Carroll JS. Corrigendum to "Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity" [Mol. Cell Endocrinol. 440 (2016) 138-150]. Mol Cell Endocrinol. 2017 Mar 05;443:175. doi: 10.1016/j.mce.2017.01.048. PMID: 28183459; PMCID: PMC6854450.
Copy Download .nbib Format: NLM
Share it on

Mol Cell Endocrinol. 2017 Mar 05;443:175. doi: 10.1016/j.mce.2017.01.048.

Corrigendum to "Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity" [Mol. Cell Endocrinol. 440 (2016) 138-150].

Molecular and cellular endocrinology

A W Nelson, A J Groen, J L Miller, A Y Warren, K A Holmes, G A Tarulli, W D Tilley, B S Katzenellenbogen, J R Hawse, V J Gnanapragasam, J S Carroll

Affiliations

  1. Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, CB2 ORE, UK; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, CB2 0QQ, UK; Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.
  2. Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, CB2 ORE, UK.
  3. Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.
  4. Dame Roma Mitchell Cancer Research Laboratories, Hanson Institute Building, School of Medicine, Faculty of Health Sciences, The University of Adelaide, SA 5005, Australia.
  5. Departments of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
  6. Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK; Department of Biochemistry and Molecular Biology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA.
  7. Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.
  8. Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, CB2 ORE, UK. Electronic address: [email protected].

PMID: 28183459 PMCID: PMC6854450 DOI: 10.1016/j.mce.2017.01.048

[No abstract available.]

Publication Types